Sofosbuvir and velpatasvir for HCV Genotype 2 and 3 infection

G. R. Foster, N. Afdhal, S. K. Roberts, N. Br, E. J. Gane, S. Pianko, E. Lawitz, A. Thompson, M. L. Shiffman, C. Cooper, W. J. Towner, B. Conway, P. Ruane, M. Bourlie, T. Asselah, T. Berg, S. Zeuzem, W. Rosenberg, K. Agarwal, C. A.M. StedmanH. Mo, H. Dvory Sobol, L. Han, J. Wang, J. McNally, A. Osinusi, D. M. Brainard, J. G. McHutchison, F. Mazzotta, T. T. Tran, S. C. Gordon, K. Patel, N. Reau, A. Mangia, M. Sulkowski

Research output: Contribution to journal › Article › peer-review

559 Scopus citations

Fingerprint

Dive into the research topics of 'Sofosbuvir and velpatasvir for HCV Genotype 2 and 3 infection'. Together they form a unique fingerprint.

Medicine & Life Sciences